Silo Pharma, Inc.
- SILO
- NASDAQ
- Biotechnology
- CNS/Pain Therapeutics
- Psychiatric Disorder Drugs
$1.13
Today −4.24%Quote Oct 19, 2026, 08:00 PM UTC
−37.23%over the last month
Max drawdown −37.2%From 1-month high −37.2%3 months −75.5%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Silo Pharma
Silo Pharma Inc. operates as a developmental-stage biopharmaceutical firm dedicated to creating treatments for a variety of underserviced medical conditions. These include stress-related psychiatric disorders, persistent pain syndromes, and diseases impacting the central nervous system (CNS).
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Employees
3
Founded
2010
Market value
$1.8M
Quote Oct 19
Floor
$1.09
3.5% below price
Resistance
$1.26
11.2% above price
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about SILOPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free